Metro Cystic Fibrosis Foundation grants Cleveland Clinic $5M for lung transplant research Published: May. 29, 2025, 10:31 a.m.

Discover how cystic fibrosis genetics affect inheritance patterns and symptom. Learn about CFTR mutations, testing options, and emerging genetic therapies.

Local Born with cystic fibrosis, he wasn’t expected to live long. Now 40, he’s fighting back By Josh Shaffer Updated May 23, 2025 11:19 AM ...

More information: Luca Richeldi et al, Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis, New England Journal of Medicine (2025). DOI: 10.1056/NEJMoa2414108 ...

But despite decades of life-changing breakthroughs, treatment for cystic fibrosis still has a long way to go. CFTR modulators only work for those with specific mutations. For the remaining 10% to 15% ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic dysfunction-associated steatotic liver disease, or MASLD. The company said ...

Liver fibrosis is the build up of scar tissue in the liver when it tries to heal itself. Symptoms may include fatigue, swelling, and weight loss.

Cystic fibrosis might sound intimidating, but tremendous advances in treatment have transformed what it means to live with this diagnosis. Children born with CF today face a very different future ...

Newly uncovered mechanism could drive next-gen cystic fibrosis treatments Date: March 13, 2025 Source: The Hospital for Sick Children Summary: Protein clustering mechanism on the cell membrane ...

Developer to seek treatment’s approval for progressive pulmonary fibrosis This is the second Phase 3 trial of nerandomilast to hit its main goal. Boehringer last year announced positive data from ...

WASHINGTON — Among patients with asymptomatic severe aortic stenosis and myocardial fibrosis, transcatheter or surgical aortic valve replacement did not improve outcomes compared with guideline ...

WASHINGTON, DC—An early aortic valve replacement (AVR) strategy with either TAVI or surgery fails to lower the risk of all-cause mortality or unplanned aortic stenosis-related hospitalizations in ...